Some of the major pharmaceutical companies such as Ranbaxy Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Dr Reddy’s Laboratories Ltd and Sun Pharmaceutical Industries Ltd have recalled their products from the world’s largest drug market, the US, in the past seven months, according to data available on US Food and Drugs Administration’s website.
Besides, a few foreign players had to recall some of their products, which were outsourced to Indian companies for manufacturing.
Recently, Dr Reddy’s recalled its anti-depression drug, Citalopram, from the US following complaints of a strong odour.
Mumbai-based Glenmark also conducted a retail or pharmacy level recall of its allergy and asthma drug, Montelukast sodium tablets, 10 mg, in February.
“The recall has been initiated based on multiple complaints received from a number of pharmacists and consumers.
"They have reported they detect an off-odour, described as moldy, musty or fishy in nature. . . After initial investigation, the source for the moldy or musty odour has been identified as the presence of trace levels of Tribromoanisole and Trichloroanisole,” Glenmark said after the recall.
Not long ago in November last year, Ranbaxy had recalled its major revenue churning generic version of Lipitor from the US after it suspected the presence of tiny glass particles in some of the batches.
While
He inspired Indian pharma to dream big and deliver
India undermining intellectual property: Pfizer
Dr Reddy's founder, chairman Anji Reddy is no more
Markets end lower amid volatility
25 COMPANIES that offer BEST pay